02:32 PM EDT, 03/24/2026 (MT Newswires) -- Outlook Therapeutics ( OTLK ) shares fell 39% in Tuesday trading after the company priced a public offering of 20 million shares at $0.25 each for gross proceeds of $5 million.
Intraday volume topped 22.9 million shares versus the daily average of 5.33 million.
Price: 0.19, Change: -0.13, Percent Change: -39.59